An Update on Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
17 Mins
Patients with osteoporosis should be recognised as being at considerably reduced risk of medication-related osteonecrosis of the jaw (MRONJ) relative to oncology patients, and risk stratified accordingly to avoid unnecessary delays to treatment.